Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-01-07 @ 9:51 AM
Study NCT ID:
NCT05528666
Status:
COMPLETED
Last Update Posted:
2022-11-08
First Post:
2022-09-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Risk Perception in Multiple Sclerosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-17
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-02
First Submit QC Date:
None
Study First Post Date:
2022-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-07
Last Update Post Date:
2022-11-08
Last Update Post Date Type:
ACTUAL